UNSPSC 51362001: Cyprazepam

This classification denotes a benzodiazepine with the molecular formula C19H18ClN3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 933N61G4SL, chemically known as 7-chloro-2-((cyclopropylmethyl)amino)-5-phenyl-3h-1,4-benzodiazepine 4-oxide but generally known as cyprazepam, which bears US NIH Compound Identifier 27452. European Medicines Agency schedules Cyprazepam in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06872MIG.

UNSPSC 51362001 Cyprazepam is a Commodity code that nominally designates a specific pharmaceutical product, yet the recent state and local procurement activity under this code shows a significant mismatch: the one recorded opportunity is Seminole County, Florida's IFB for naloxone and safe drug deactivation systems, neither of which are cyprazepam. The county's competitive bidding solicitation sought 1,900 units of naloxone and 800 safe drug deactivation systems annually for community health initiatives, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. Vendors were required to include all shipping and delivery costs, comply with E-Verify and drug-free workplace certification, maintain specified insurance coverages, and accept a three-month probationary termination clause. The contract carried a two-year initial term with an option for one-year renewal and potential FEMA funding, which triggered additional federal compliance requirements including Clean Air Act and Federal Water Pollution Control Act adherence.

The recent state and local procurement records show minimal activity under this code. Seminole County's naloxone procurement was posted on June 30, 2026, with a response deadline of July 26, 2023 — a date that appears inconsistent with the posting date and likely reflects data entry error in the source record. The code shows no additional verified opportunities, no clear pattern of repeat buyers, and no geographic spread beyond the single Seminole County record. Because the sole opportunity targets products outside cyprazepam's pharmaceutical scope, this code does not reflect active state and local market demand for the nominal commodity and warrants close review before resource allocation.